Treatment of congestion in heart failure with diuretics and extracorporeal therapies: Effects on symptoms, renal function, and prognosis

Heart Failure Reviews

Volumn 17, Issue 2, 2012, Pages 313-324

  Costanzo, Maria Rosa ^a   Jessup, Mariell ^b  

^a Edward Heart Hospital   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Congestion; Diuretics; Extracorporeal fluid removal; Heart failure

Indexed keywords

DIURETIC AGENT; DOPAMINE; ELECTROLYTE; FUROSEMIDE; ISOTONIC SOLUTION; LOOP DIURETIC AGENT; NEUROHORMONE; NITRATE; SODIUM; THIAZIDE DIURETIC AGENT;

ACUTE HEART FAILURE; ARTICLE; BLOOD; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DATA ANALYSIS; DISEASE COURSE; DISEASE REGISTRY; DIURESIS; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG RESPONSE; DYSPNEA; ELECTROLYTE BLOOD LEVEL; EPIDEMIOLOGICAL DATA; EUROPE; EXTRACORPOREAL THERAPY; FLUID RETENTION; HEART FAILURE; HEART OUTPUT; HEMODYNAMICS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYDROSTATIC PRESSURE; INTERMITTENT ISOLATED ULTRAFILTRATION; KIDNEY DISEASE; KIDNEY FUNCTION; LIQUID; LOW DRUG DOSE; MEMBRANE PERMEABILITY; PATHOPHYSIOLOGY; PLASMA; PROGNOSIS; SALT INTAKE; SCORING SYSTEM; SIMPLIFIED ISOLATED ULTRAFILTRATION; SODIUM RETENTION; SOLUTE; SURVIVAL; SYMPTOM; THERAPY; ULTRAFILTRATION; UNITED STATES; VASCULARIZATION; VENOUS CONGESTION; WORSENING RENAL FUNCTION;

DISEASE PROGRESSION; DIURETICS; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPEREMIA; PROGNOSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; ULTRAFILTRATION;

EID: 84862586284     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9248-0     Document Type: Article

References (75)

1. Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics-2010 update. A report from the American Heart Association Statistics. Circulation 121: e46-e215
2. Adams KF, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149: 209-216
3. Jain P, Massie BM, Gattis WA et al (2003) Current medical treatment for exacerbation of chronic heart failure resulting in hospitalization. Am Heart J 145: S3-S17
4. Drazner MH, Rame JE, Stevenson LW, Dries DL (2001) Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345: 574-581
5. Androne AS, Katz SD, Lund L et al (2003) Hemodilution is common in patients with advanced heart failure. Circulation 107: 226-229
6. Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 119: 1977-2016
7. Schrier RW (2006) Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor? J Am Coll Cardiol 47: 1-8
8. Ellison DH (2001) Diuretic therapy and resistance in congestive heart failure. Cardiology 96: 132-143
9. Francis GS, Benedict C, Johnstone DE et al (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729
10. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E (2003) Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42: 705-708
11. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P (2001) Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38: 963-968
12. Rimondini A, Cipolla C, Della Bella P et al (1987) Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 83: 43-48
13. Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT (2003) Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 9: 227-231
14. Jong P, Vowinkel E, Liu PP et al (2002) Prognosis and determinants of survival in patients newly hospitalized for heart failure. A population-based study. Arch Intern Med 162: 1689-1694
15. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW (2007) Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 153: 1021-1028
16. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J (2007) High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13: 422-430
17. Gheorghiade M, Filippatos G, De Luca L, Burnett J (2006) Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119: S3-S10
18. Adamson PB, Magalski A, Braunschweig F et al (2003) Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41: 565-571
19. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM (2007) Patterns of weight change preceding hospitalization for heart failure. Circulation 116: 1549-1554
20. Ahmed A, Allman RM, Fonarow GC et al (2008) Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 14: 211-218
21. Gheorghiade M, Filippatos G (2005) Reassessing treatment of acute heart failure syndromes: the ADHERE registry. Eur Heart J 7(Suppl): B13-B19
22. Gheorghiade M, Abraham WT, Albert NM et al (2007) Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 28: 980-988
23. Wang NC, Maggioni AP, Konstam MA et al (2008) Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 299: 2656-2666
24. Gheorghiade M, Abraham WT, Albert NM et al (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296: 2217-2226
25. Gheorghiade M, Gattis WA, O'Connor CM et al (2004) Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291: 1963-1971
26. Steimle AE, Stevenson LW, Chelimski-Fallick C (1997) Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 96: 1165-1172
27. Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589-596
28. Schrier RW (1990) Body fluid regulation in health and disease: a unifying hypothesis. Ann Intern Med 113: 155-159
29. Castrop H, Schweda F, Mizel D et al (2004) Permissive role of nitric oxide in macula densa control of renin secretion. Am J Physiol Renal Physiol 286: F848-F857
30. Firth JD, Raine AE, Ledingham JG (1988) Venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1(8593): 1033-1035
31. Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51: 1268-1274
32. Schrier RW (2008) Blood urea nitrogen and serum creatinine. Not married in heart failure. Circ Heart Fail 1: 2-5
33. Klein L, Massie BM, Leimberger JD et al (2008) Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbation of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 1: 25-33
34. Ellison DH (1999) Diuretic resistance: physiology and therapeutics. Semin Nephrol 19: 581-597
35. Rubboli A, Sobotka PA, Euler DE (1994) Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol Heart Circ Physiol 267: H1054-H1061
36. Peacock WF, De Marco T, Fonarow GC et al (2008) Cardiac troponin and outcome in acute heart failure. N Engl J Med 358: 2117-2126
37. Ronco C, House AA, Haapio M (2008) Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 34: 957-962
38. Mielniczuk LM, Tsang SW, Desai AS, Nohria A, Lewis EF, Fang JC, Baughman KL, Stevenson LW, Givertz MM (2008) The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. J Card Fail 14: 388-393
39. Butler J, Forman DE, Abraham WT et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized heart failure patients. Am Heart J 147: 331-338
40. Hasselblad V, Gattis Stough W, Shah M et al (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9: 1064-1069
41. Cotter G, Weissgarten J, Metzkor E et al (1997) Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 62: 187-193
42. Cotter G, Metzkor E, Kaluski E et al (1998) Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351: 389-393
43. Peacock WF, Costanzo MR, De Marco T et al (2008) Impact of intravenous diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 113: 12-19
44. Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10: 188-195
45. Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies evaluation in patients with acute decompensated heart failure. N Engl J Med 364: 797-805
46. Peters J (1948) The role of sodium in the production of edema. N Engl J Med 239: 353-362
47. Marenzi G, Grazi S, Giraldi F, Lauri G, Perego G, Guazzi M, Salvioni A, Guazzi MD (1993) Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 941: 49-56
48. Pepi M, Marenzi GC, Agostoni PG, Doria E, Barbier P, Muratori M, Celeste F, Guazzi MD (1993) Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. Br Heart J 702: 135-140
49. Agostoni PG, Marenzi GC, Pepi M, Doria E, Salvioni A, Perego G, Lauri G, Giraldi F, Grazi S, Guazzi MD (1993) Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 212: 424-431
50. Agostoni PG, Marenzi GC, Sganzerla P, Assanelli E, Guazzi M, Perego GB, Lauri G, Doria E, Pepi M, Guazzi MD (1995) Lungheart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure. Am J Cardiol 7611: 793-798
51. Cipolla CM, Grazi S, Rimondini A, Susini G, Guazzi M, Della Bella P, Guazzi MD (1990) Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am J Cardiol 612: 987-994
52. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD (1994) Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 963: 191-199
53. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P (2005) Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 4611: 2047-2051
54. Coraim FI, Wolner E (1995) Continuous hemofiltration for the failing heart. New Horiz 3: 725-731
55. Canaud B, Leblanc M, Leray-Moragues H et al (1998) Slow continuous ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 13(Suppl 4): 51-55
56. Bellomo R, Ronco C (1998) Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int 66(Suppl): S106-S109
57. Bellomo R, Ronco C (1999) Renal dysfunction in patients with cardiac disease and after cardiac surgery. New Horiz 7: 524-532
58. Asaba H, Bergstrom J, Furst P et al (1978) Treatment of diuretic resistant fluid retention with ultrafiltration. Acta Med Scand 204: 145-149
59. Gerhardt RE, Abdulla AM, Mach SJ et al (1979) Isolated ultrafiltration in the treatment of fluid overload in cardiogenic shock. Arch Intern Med 139: 358-359
60. Bart BA (2009) Ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure. Circ Heart Fail 2: 499-504
61. Bart BA, Boyle A, Bank AJ et al (2005) Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: relief for acutely fluid overloaded patients with decompensated congestive heart failure. J Am Coll Cardiol 46: 2043-2046
62. Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49: 675-683
63. Costanzo MR, Saltzberg MT, Jessup M et al (2010) Ultrafiltration is associated with fewer re-hospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 16: 277-284
64. Ali SS, Olinger CC, Sobotka PA et al (2009) Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail 15: 1-4
65. Konstam MA, Gheorghiade M, Burnett JC, for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure. The EVEREST outcome trial. JAMA 297: 1319-1331
66. Abdallah JG, Schreier RW, Edelstein C et al (2001) Loop diuretic infusion increases thiazide-sensitive Na?/Cl- cotransporter abundance: role of aldosterone. J Am Soc Nephrol 12: 1335-1341
67. Domanski M, Tian X, Haigney M, Pitt B (2006) Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail 12: 327-332
68. He XR, Greenberg S, Briggs J, Schnermann J (1995) Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated secretion. Hypertension 26: 137-142
69. Nielsen S, Knepper M, Kwon T et al (2001) Regulation of water balance. In: Schrier RW (ed) Diseases of the kidney and urinary tract, 7th edn. Lippincott Williams and Wilkins, New York, pp 109-134
70. Fang J, Mensah GA, Croft JB, Keenan NL (2008) Heart failurerelated hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52: 428-434
71. Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, Gottlieb SS (2008) A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail 14: 1-5
72. Howlett JG, McKelvie RS, Costigan J et al (2010) The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol 26: 185-202
73. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur Heart J 29: 2388-2442
74. Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL (2006) Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114: 1572-1580
75. Bartone C, Saghir S, Menon SG et al (2008) Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure. Congest Heart Fail 14: 298-301